Perbedaan Bangun Kosambi Sukses Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Bangun Kosambi Sukses Tbk. diperdagangkan di Rp3.500 (kapitalisasi pasar 19,5 T, volume 24 jam 1,85 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Bangun Kosambi Sukses Tbk. jauh lebih besar — sekitar 116,5× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Bangun Kosambi Sukses Tbk. lebih aktif diperdagangkan (1,85 jt vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CBDK | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 19,5 T | 167,37 M |
Volume | 1,85 jt | 71 rb |
Lot | 18,52 rb | 710 |
Perputaran | 6,5 M | 17,51 jt |
Harga Rata-rata | 3.512,14 | 246,63 |
Nilai Transaksi | 6,5 M | 17,51 jt |
Harga Ekuilibrium Indikatif | 3.500 | 246 |
Volume Ekuilibrium Indikatif | 522 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Bangun Kosambi Sukses Tbk (the Company) was established based on Notarial Deed No. 01 of Djedjem Widjaja, S.H., M.H., dated 3 April 2000. The Company commenced its commercial operations in 2020. The Company is controlled by its immediate parent company, PT Pantai Indah Kapuk Dua Tbk, domiciled in Jakarta and its ultimate parent companies are PT Agung Sedayu and PT Tunas Mekar Jaya, domiciled in Jakarta.
Selengkapnya di halaman CBDK →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →